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Abstract
Renal salt wasting syndrome (RSW) is defined as a renal loss of sodium leading to hyponatremia and a decrease in extracel-
lular fluid volume (ECV). Differentiation of this disorder from the syndrome of inappropriate antidiuretic hormone secretion 
(SIADH), a common cause of hyponatremia, can be difficult because both can present with hyponatremia and concentrated 
urine with natriuresis. Our clinical case about a 78-year-old woman with a recent fracture of the right femur not only confirms 
that this syndrome can occur in patients without intracranial pathologies (CT documented), but depicts how the hypona-
tremia caused by RSW can show a chronic, oscillating course. This is an interesting point of view because it suggests to us 
to consider RSW in the differential diagnosis of patients with chronic hyponatremia.
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Background
Cerebral salt wasting syndrome (CSW) was first described 
by Peters et al. in 1950 in a report of three patients with neu-
rogenic diseases and hyponatremia [1], but the identification 
7 years later of the Syndrome of Inappropriate Antidiuretic 
Hormone Secretion (SIADH) by Schwartz et al. eventually 
eclipsed the interest of the researchers since, given the over-
lap of the clinical and laboratory characteristics of the two 
syndromes, CSW was considered a misnomer of SIADH [2]. 
Indeed, some authors even doubted the existence of CSW. 
However, in recent years the interest of authors has returned 
to the study of this syndrome through the publication of case 
reports, reviews and other studies. In particular among neu-
rosurgeons, CSW is considered a fairly frequent syndrome.
However, internists and nephrologists have also reeval-
uated this syndrome and propose to rename it Renal Salt 
Wasting syndrome (RSW) since cases have been described 
in the absence of brain diseases. We believe that the name 
of RSW is more correct in consideration of our clinical case 
[3]. Despite the recent increase in interest of researchers, 
this syndrome remains controversial, and many authors are 
sceptical towards it. The reasons for this attitude are dif-
ferent, starting from the uncertainty about the name to be 
given to the syndrome (recently the shift from CSW to RSW 
has been proposed), the lack of universally recognized and 
defined diagnostic criteria, and the lack of knowledge of 
pathophysiological mechanisms responsible for the onset 
of this syndrome (conditions that also determine a difficult 
understanding of the real incidence and prevalence of this 
pathology). However, in view of the increasing number of 
clinical cases described in the literature and the clinical 
case reported in this article that shows that only a RSW can 
explain a so marked polyuria with hyponatremia and renal 
sodium loss in an otherwise healthy patient, we believe it 
is right to continue with scientific efforts to shed light on 
this syndrome whose existence is now certain, and whose 
knowledge will allow us to understand further the interesting 
aspects of water and sodium homeostasis, and in particu-
lar, the functioning of the complex “puzzle of natriuretic 
peptides”.
The purpose of this point of view is to further confirm 
the existence of this syndrome, the importance of the 
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recognition of RSW, and to underline how this syndrome 
can determine chronic alterations of natremia and conse-
quently neurological changes (balance changes, attention 
deficit, memory changes) and bone changes (osteoporosis, 
increased risk of fracture).
Index case
On July 27, a 78-year-old woman suffered a pertrochanteric 
fracture of the right femur following an accidental fall, and 
was treated with osteosynthesis. She was discharged from 
the orthopaedics ward on August 3 and later, on August 
27, admitted to a neuromotor rehabilitation centre. During 
this hospitalization she was found to have a hyponatremia 
poorly responsive to NaCl supplementation, so it was the 
thiazide diuretic therapy with which the patient was being 
treated, was withdrawn. She was discharged on September 
29, but, the next day, alteration of the state of conscious-
ness occurred associated with three episodes of nausea and 
vomiting. For this reason, the patient was admitted to our 
Department on October 1. The past medical history revealed 
that the patient suffered from arterial hypertension treated 
with angiotensin receptor blockers/hydrochlorothiazide 
(ARB/HCT), Paroxysmal Atrial Fibrillation treated with 
beta-blocker and gastroesophageal reflux disease (GERD) 
treated with proton pump inhibitor (PPI). Moreover, dur-
ing the prior year relatives recount episodes of amnesia, 
attention deficit and postural instability that were revealed 
after an accidental fall with consequent fracture of the left 
humerus that was treated conservatively. Physical examina-
tion showed that the patient was confused with a tendency 
to fall asleep, but reawakening with verbal stimuli (Glasgow 
coma scale 14), mild hypotension (100/68 mmHg) and no 
peripheral edema, body weight was about 50 kg and she 
was 1.50 m high. The blood chemistry tests revealed the 
presence of severe hyponatraemia (120 mEq/l), potassium 
4.5 mEq/l, uricemia 1.9 mg/dl, calcium 9.58 mg/dl, normal 
indices of renal function (Creatinine 0.4 mg/dl, eGFR 85 ml/
min with CKD-EPI, Azotemia 24 mg/dl), Plasma osmolarity 
263 mOsm/KgH2O, NT-proBNP 834 pg/ml. Arterial blood 
gas analysis was normal (pH 7.427, pCO2 37.7 mmHg,  pO2 
82.9 mmHg,  HCO3–24.4 mmol/l, Lac 1.2 mmol/l). Urine 
chemistry showed Urine Na (UNa) 44 mEq/l, Urine osmo-
larity 468.93 mOsm/KgH2O, absence of proteinuria. Cer-
ebral CT performed in the emergency department before 
arriving at our department showed no noteworthy altera-
tions. Her medications during hospitalization included pan-
toprazole, bisoprolol, and enoxaparin. In light of the clinical 
picture, the study for the classification of hyponatremia was 
started (serum TSH, ACTH and cortisol were measured), 
and, despite laboratory values suggesting a diagnosis of the 
syndrome of inappropriate antidiuretic hormone secretion 
(SIADH), (hyponatremia associated with plasma hyposmo-
larity, urinary hyperosmolarity and UNa > 40 mEq/l), the 
presence of mild hypotension and alteration of the state of 
consciousness leading to the administration of NaCl associ-
ated with commensurate volumes of water to maintain an 
adequate hydration of the patient through the administration 
of isotonic saline solution at about 42 ml/h (approximately 
1000 ml/day). The subsequent laboratory tests showed no 
endocrine abnormalities: TSH 2.33 µU/ml (r.r. 0.27–4.2), 
ACTH at 08:00 a.m. 12.4 pg/ml (r.r. 7.9–66.1), Cortisol at 
08:00 a.m. 11.75 µg/dl (r.r. 7–28). At this point, the diagno-
sis of SIADH seemed the most probable, but, unexpectedly, 
in the days following entry into our ward an intense polyu-
ria was observed (from a minimum of 3200 ml/day up to a 
maximum of 8200 ml/day, with an average of 5400 ml/day) 
(Fig. 1). It caused dehydration of the patient, and required 
an increase of isotonic saline infusion up to 150 ml/h. Such 
infusion therapy has allowed the progressive even if slow 
increase of natremia values (about 3 mEq/day), and the rapid 
improvement of the patient’s awareness in that she was able 
to start drinking again, thus reinstating the urinary losses 
together with the infusive therapy. It should be noted that 
an accurate fluid balance was made every day by assessing 
water intake and loss according to the common methods 
used in clinical practice, which indicate when we are faced 
with a frankly positive or negative balance as in this case. 
So what can explain a so marked diuresis with a frankly 
negative fluid balance in a hyponatremic patient with the 
laboratory values mentioned above, without alterations of 
the GFR, absent diuretics and without other obvious causes 
of polyuria? The answer can only be a renal salt wasting 
syndrome (RSW).
Outcome and clinical follow‑up
The patient was discharged after 9 days of hospitalization 
in good clinical condition, with a salt-based therapy (1 g 
NaCl tablets twice a day), and with the instruction to drink 
at least 1.5 l of water per day. Laboratory tests 2 weeks and 
2 months after discharge showed, respectively, a sodium of 
135 mEq/l and 142 mEq/l. However, whenever we tried to 
stop treatment with NaCl, natremia again tended to shrink, 
so the patient continued to take the 1 g NaCl tablets twice 
a day. About 4 months later from the last control, hypona-
tremia was found again (127 mEq/l), so an increase in salt-
therapy was recommended (1 g NaCl tablets three times a 
day). The patient was lost in subsequent follow-up.
Clinical case discussion
Our clinical case not only confirms that RSW can occur in 
patients without intracranial pathologies, but highlights how 
this syndrome can take a sub-acute or chronic course that 
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can evolve into episodes of acuteness with rapidly worsen-
ing of hyponatremia and consequent alteration of the state 
of conscience if the disorder is not treated properly. Our 
patient suffered a fracture of the femoral neck 2 months 
before reaching our attention, so it took 2 months from the 
acute event to the development of an evident RSW. In this 
regard, it is interesting to note that the first case of RSW in 
the absence of intracranial disorders described in the lit-
erature concerns a 76-year-old woman with a femoral neck 
fracture [3]. The cases described in the literature, especially 
concerning patients with intracranial diseases, describe 
the development of RSW usually within 10 days of the 
acute event. In our case, however, not only did 2 months 
pass from the acute event to the development of evident 
RSW with severe hyponatraemia, but the negative altera-
tion of sodium balance lasted for at least other 6 months 
from discharge. The documentation presented by the patient 
showed that already during the admission to a neuromotor 
rehabilitation centre (which took place about a month after 
the fracture), a treatment-resistant hyponatraemia emerged 
that was imputed to the HCT therapy hitherto being fol-
lowed by the patient. However, despite the suspension of 
this drug, hyponatremia persisted and even got worse reach-
ing very low levels (120 mEq/l), and causing alteration of 
the state of consciousness. Even after discharge from our 
internal medicine department, the patient continued to have 
low serum levels that required additional oral NaCl therapy, 
which could not be stopped due to rebound hyponatremia. 
Moreover, about 6 months after discharge (a period during 
which the patient has always taken a 1 g supplement of NaCl 
two times a day) there was a new reduction of the natremia 
that required an increase in additional therapy with NaCl. 
This alteration of sodium homeostasis that has been going 
on for several months is reasonably attributable to a RSW 
syndrome, and we can state this as a consequence of the 
considerations described below (it is also to underline that 
ours is not the first case of RSW described in the literature 
in which the alteration of sodium balance is maintained for 
several months after the discharge of the patient [4, 5]). We 
have documented that our patient had suffered from hypona-
tremia for at least 7 months, although this condition could 
have existed for a long time considering the related humerus 
fracture following accidental fall a year before the current 
hospitalization, and the recently described association 
described in the literature between chronic hyponatremia 
and increased risk of falls and fractures. During hospitaliza-
tion it was shown that, at that time, hyponatremia was due 
to a RSW. Thus, it is logical to assume that, in the absence 
of additional external factors (such as the appearance of 
other acute pathologies or the introduction of new drugs), 
the same mechanism has been responsible for the hypona-
tremia in the period between the fracture of the femur and 
the hospitalization (the period during which the Patient took 
HCT but the suspension of the latter not only did not resolve 
hyponatremia, but also did not avoid the reduction of sodium 
up to 120 mEq/l), and in the period subsequent to admission.
Chronic hyponatremia in renal salt wasting 
syndrome
The report of our clinical case explains that it is possible 
to think that in addition to presenting itself in an “acute” 
form (the cases described in the literature usually resolve 
within a month), RSW may present in a subacute or chronic 
form with possible oscillations over time. Among the main 
Fig. 1  Water balance of our 
patient during hospitalization
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causes of RSW are the alteration of sympathetic renal affer-
ents and an increase in the production of natriuretic peptides 
[6]. The increased production of these peptides is balanced 
by adequate secretion of antidiuretic hormone (ADH) under 
the hypovolemic stimulus (which is stronger than the hypo-
osmolar stimulus that would tend to inhibit the secretion of 
ADH), resulting in a condition of chronic hyponatremia. If 
extracellular volume (ECV) is decreased due to RSW, the 
baroreceptors are triggered, and ADH is secreted to restore 
intravascular volume. The stimulus for ADH secretion by the 
reduced ECV is more potent than the osmolar effect on ADH 
secretion, so the patient remains hyponatremic despite the 
hypoosmolality. This defines the appropriateness of ADH 
secretion in RSW, and why saline can remove the volume 
stimulus for ADH secretion and allow the hypoosmolarity 
to inhibit ADH secretion, increase free water excretion and 
correct the hyponatremia [7].
Relationship between RSW, risk of fractures 
and cognitive impairment: a possible role 
for natriuretic peptides
Chronic hyponatremia in RSW may have important impli-
cations considering that there is a growing awareness that 
mild hyponatremia is associated with mental dysfunction, 
unsteady gait, osteoporosis, increased falls and bone frac-
tures [8–10]. Moreover, some authors have investigated the 
direct effects of chronic hyponatremia on bone and brain 
metabolism [11, 12]. However, in addition to the direct 
effects of hyponatremia on the bone and brain, we must con-
sider that the relationship between natremia, cognitive func-
tions and bone metabolism could be even closer than what 
has been described so far, and the trait d’union could be the 
complex natriuretic peptide system. Consider for example 
the role of atrial natriuretic peptide (ANP), brain natriu-
retic peptide (BNP) and C-type natriuretic peptide (CNP) 
in brain metabolism. ANP and BNP can be used as markers 
for Alzheimer’s disease as well as stroke, and are possibly 
involved in the pathophysiological mechanisms of these dis-
eases [13, 14]. CNP, which acts unlike ANP and BNP locally 
in an autocrine or paracrine manner, appears to be the natriu-
retic peptide with a prominent role in the brain physiology. 
Indeed, though all natriuretic peptides (NPs) and their recep-
tors can be found in the brain, natriuretic peptide receptor-B 
and it’s binding hormone CNP are the most abundant in the 
brain. For example in the hypothalamus, CNP expression 
is 50 times higher compared to ANP and BNP [15]. There 
are three known natriuretic peptide binding proteins: natriu-
retic peptide receptor-A, natriuretic peptide receptor-B and 
natriuretic peptide receptor-C (NPR-A, NPR-B and NPR-C). 
Whereas NPR-C primarily controls local natriuretic peptide 
concentrations via receptor-mediated internalization and 
degradation, NPR-A and NPR-B are the main mediators of 
the effects of natriuretic peptides on natremia and on tissue 
metabolism. They are guanylate cyclase receptors, so they 
signal by catalyzing the synthesis of the intracellular sig-
nalling molecule cyclic guanosine monophosphate (cGMP) 
[16]. cGMP, regardless of its source (NO, and soluble gua-
nylate cyclase or NPs and their receptors) plays an impor-
tant role in brain physiology. Its actions are of particular 
importance regarding modulations of long-term changes of 
synaptic activity in the hippocampus, amygdala, cerebellum 
(by pre-synaptic transmitter release [17]) and post-synaptic 
functions via activation of different protein kinase G (PKG) 
isoforms [18]. Recent studies show a neuroprotective role of 
NPs and the cGMP signalling pathway. An increase of intra-
cellular cGMP concentration protects neurons against exci-
totoxic, metabolic, oxidative damages as well as N-methyl 
d-aspartate (NMDA)-induced neurotoxicity [19]. Despite 
the abundance of the evidence suggesting that NPs play an 
important physiological role in certain pathophysiological 
conditions such as stroke and brain trauma, there still remain 
many unanswered questions.
But NPs, and in particular the CNP, possess other impor-
tant properties, and also come into play in the modulation 
of the bone metabolism. Our case is the second clinical case 
described in the RSW literature diagnosed following femoral 
fracture [7]. Maesaka et al. describe a similar case, also in 
that case concerning an elderly patient without the evidence 
of intracerebral pathology [7]. CNP plays an important role 
in bone metabolism as it stimulates endochondral ossifica-
tion and elongates bones, as evidenced by the skeletal phe-
notypes of transgenic and knockout [20].
Therefore, summing up, the neurological and bone 
changes observed in patients with RSW and chronic hypona-
tremia may be mediated not only by the hyponatremia itself, 
but by an “impairment” of the NPs system in which a rela-
tive increase in the activity of properly natriuretics peptides 
is determined (with consequent establishment of chronic 
hyponatraemia) to the detriment of a reduction in CNP activ-
ity with possible metabolic repercussions at bone and brain 
level.
Conclusions
RSW is a syndrome whose existence is now certain, how-
ever, it still has many aspects on which it is necessary to 
shed light. Our clinical case not only confirms that this syn-
drome can occur in patients without intracranial pathologies 
(CT documented), but shows how the hyponatremia caused 
by RSW can take a chronic, oscillating course. This is an 
interesting aspect because it suggests the consideration of 
RSW in the differential diagnosis of patients with chronic 
hyponatremia, a condition that must be treated to prevent 
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neurological changes (balance changes, attention deficit, 
memory changes) and bone changes (osteoporosis, increased 
risk of fracture).
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